NCT07558460Enrolling by invitation
Virtual Reality in Patients With Pulmonary Hypertension: A Randomized Controlled Trial
Effectiveness of Exercise Training Applied Through Virtual Reality in Patients With Pulmonary Hypertension
Source: ClinicalTrials.gov · Last updated 30 Apr 2026
Brief summary (registry, in English)
The goal of this research is to investigate the effectiveness of exercise administered via immersive virtual reality in patients with pulmonary hypertension, thereby contributing to the existing literature on this subject. The main question is whether exercises delivered via immersive virtual reality are effective to improve physical performance, functional capacity, dyspnea, muscle strength, fatigue, quality of life, depression and anxiety.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- First submitted
- 19 Apr 2026
- Start date
- 31 Jan 2026
- Primary completion date
- 31 Jan 2027
- Lead sponsor
- Istanbul University - Cerrahpasa
- NCT number
- NCT07558460
What you commit to
- Study type: Interventional
- Planned participants: 32
- From 31 Jan 2026 to the primary completion date, 31 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Acute decompensated heart failure,
- Unstable angina pectoris,
- Uncontrolled hypertension,
- Severe visual impairment,
Other
- The presence of an orthopedic or neurological problem that will affect functional tests and muscle strength measurement,
- The presence of problems that hinder communication,
- Dizziness, vertigo,
Who the study is looking for
- Diagnosis of Idiopathic Pulmonary Arterial Hypertension,
- Stable pharmacological treatment for the past 3 months,
- Hemodynamic and clinical stability for at least the past three months,
- Age of 18-65,
- Voluntary participation in the study and signing the informed consent form,
- Being classified in the World Health Organization-Functional Classification I, II or III.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istanbul University-Cerrahpaşa, Cardiology Institute Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.